Literature DB >> 6265357

Cell-produced viral inhibitor: possible mechanism of action and chemical composition.

T K Hughes, J E Blalock, M L McKerlie, S Baron.   

Abstract

A newly recognized cell-produced viral inhibitor appeared to be spontaneously released from most cells in tissue culture. It strongly inhibited the replication of a variety of viruses but did not exhibit species specificity as does interferon. These studies on the inhibitor's mechanism of action indicated that it inhibited attachment and penetration of virus by a readily reversible reaction requiring the presence of both virus and cells. Studies of inactivation by specific enzymes or chemicals indicated that for activity the inhibitor required intact protein but not lipid, carbohydrate, deoxyribonucleic acid, or ribonucleic acid.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6265357      PMCID: PMC351465          DOI: 10.1128/iai.32.2.454-457.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  7 in total

1.  The clinical use of gamma globulin.

Authors:  S KRUGMAN
Journal:  N Engl J Med       Date:  1963-07-25       Impact factor: 91.245

2.  Interferon produced by cultures of calf kidney cells.

Authors:  D A TYRRELL
Journal:  Nature       Date:  1959-08-08       Impact factor: 49.962

Review 3.  Superinduction of interferon with metabolic inhibitors: possible mechanisms and practical applications.

Authors:  J Vilcek; E A Havell; M Kohase
Journal:  J Infect Dis       Date:  1976-06       Impact factor: 5.226

4.  Stimulation of density-inhibited cell cultures by insulin.

Authors:  A Vaheri; E Ruoslahti; T Hovi; S Nordling
Journal:  J Cell Physiol       Date:  1973-06       Impact factor: 6.384

5.  A solvent system for delipidation of plasma or serum without protein precipitation.

Authors:  B E Cham; B R Knowles
Journal:  J Lipid Res       Date:  1976-03       Impact factor: 5.922

6.  Broadly active inhibitor of viruses spontaneously produced by many cell types in culture.

Authors:  S Baron; L McKerlie
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

Review 7.  Human immunoglobulin in prophylaxis.

Authors:  T M Pollock
Journal:  Br Med Bull       Date:  1969-05       Impact factor: 4.291

  7 in total
  6 in total

1.  Interferon induction with polyinosinic:polycytidylic acid in the newborn piglet.

Authors:  K G Loewen; J B Derbyshire
Journal:  Can J Vet Res       Date:  1986-04       Impact factor: 1.310

2.  Fetal rhesus monkey lung cells can be grown in serum-free medium for the replication of dengue-2 vaccine virus.

Authors:  B Malewicz; L E Anderson; K Crilly; H M Jenkin
Journal:  In Vitro Cell Dev Biol       Date:  1985-08

3.  Broadly active inhibitor of viruses spontaneously produced by many cell types in culture.

Authors:  S Baron; L McKerlie
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

4.  Size and stability of a naturally occurring virus inhibitor.

Authors:  D H Coppenhaver; J L Baron; M L McKerlie; J Sabados; S Baron
Journal:  Antimicrob Agents Chemother       Date:  1984-05       Impact factor: 5.191

Review 5.  Innate antiviral defenses in body fluids and tissues.

Authors:  S Baron; I Singh; A Chopra; D Coppenhaver; J Pan
Journal:  Antiviral Res       Date:  2000-11       Impact factor: 5.970

Review 6.  Recently described innate broad spectrum virus inhibitors.

Authors:  S Baron; D Niesel; I P Singh; L McKerlie; J Poast; A Chopra; G Antonelli; F Dianzani; D H Coppenhaver
Journal:  Microb Pathog       Date:  1989-10       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.